Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Calix
CALX
$2.39B
| $412K | ﹤0.01% |
27,673
+12,094
| +78% | +$139K |
|
|
OLP
3452
One Liberty Properties
OLP
$527M
| $412K | ﹤0.01% |
23,390
+11,302
| +93% | +$179K |
|
3453
UroGen Pharma
URGN
$2.29B
| $412K | ﹤0.01% |
15,751
+5,367
| +52% | +$131K |
|
3454
DHT Holdings
DHT
$3.02B
| $411K | ﹤0.01% |
80,087
+25,312
| +46% | +$161K |
|
|
FFIC
3455
DELISTED
Flushing Financial
FFIC
| $411K | ﹤0.01% |
35,670
+10,702
| +43% | +$122K |
|
|
JNPR
3456
PUT
DELISTED
Juniper Networks
JNPR
| $411K | ﹤0.01% |
18,000
-17,300
| -49% | -$398K |
|
3457
PUT
Stratasys
SSYS
$774M
| $411K | ﹤0.01% |
25,900
-14,600
| -36% | -$247K |
|
3458
Alpha Metallurgical Resources
AMR
$1.93B
| $409K | ﹤0.01% |
134,423
-48,211
| -26% | -$173K |
|
3459
HUTCHMED
HCM
$2.17B
| $409K | ﹤0.01% |
14,836
+1,836
| +14% | +$39.8K |
|
3460
Columbia Financial
CLBK
$1.13B
| $408K | ﹤0.01% |
29,219
+4,097
| +16% | +$57.2K |
|
3461
DXP Enterprises
DXPE
$2.98B
| $408K | ﹤0.01% |
20,463
+6,651
| +48% | +$107K |
|
3462
PUT
Teck Resources
TECK
$32.6B
| $408K | ﹤0.01% |
39,200
-35,100
| -47% | -$322K |
|
|
CZR
3463
PUT
DELISTED
Caesars Entertainment Corporation
CZR
| $408K | ﹤0.01% |
33,600
-321,600
| -91% | -$3.25M |
|
3464
CALL
Dillards
DDS
$9.56B
| $407K | ﹤0.01% |
15,800
-19,500
| -55% | -$551K |
|
|
TPIC
3465
DELISTED
TPI Composites
TPIC
| $406K | ﹤0.01% |
17,375
+7,098
| +69% | +$133K |
|
3466
National Presto Industries
NPK
$989M
| $405K | ﹤0.01% |
4,635
+494
| +12% | +$42K |
|
|
AUY
3467
CALL
DELISTED
Yamana Gold, Inc.
AUY
| $405K | ﹤0.01% |
74,100
-160,800
| -68% | -$768K |
|
|
CERN
3468
CALL
DELISTED
Cerner Corp
CERN
| $404K | ﹤0.01% |
5,900
-6,600
| -53% | -$454K |
|
3469
PUT
Cadence Design Systems
CDNS
$93.4B
| $403K | ﹤0.01% |
4,200
-2,200
| -34% | -$184K |
|
3470
Marcus Corp
MCS
$945M
| $403K | ﹤0.01% |
30,365
+10,413
| +52% | +$140K |
|
3471
Telephone and Data Systems
TDS
$3.75B
| $403K | ﹤0.01% |
20,269
+17,058
| +531% | +$326K |
|
3472
CALL
TripAdvisor
TRIP
$1.26B
| $403K | ﹤0.01% |
21,200
-15,200
| -42% | -$290K |
|
3473
Caesarstone
CSTE
$79.5M
| $402K | ﹤0.01% |
33,911
+4,878
| +17% | +$51.3K |
|
3474
CALL
Vodafone
VOD
$37.4B
| $402K | ﹤0.01% |
25,200
-184,500
| -88% | -$2.78M |
|
3475
CALL
Caesars Entertainment
CZR
$6.14B
| $401K | ﹤0.01% |
10,000
-35,000
| -78% | -$970K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.